Break it Down: Osteopore seeking to raise $20 million

Australian-Singaporean regenerative medicine company Osteopore announced today it is undertaking a $20 million raising.

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Sarah Hughan dissects Osteopore's (ASX:OSX) plans to raise $20m via a redeemable convertible note issue.

The regenerative medicine company, working in the 3D-printed biomimetic and bioresorbable implants, is undertaking the raising via Advance Opportunities Fund.

Tune in to get the latest.

Originally published as Break it Down: Osteopore seeking to raise $20 million